Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa Randomized, Controlled Study of Combination Therapies to Treat COVID-19 Infection

NCT04459702 is registered in ClinicalTrials.gov with ProgenaBiome as lead sponsor.

NCT NCT04459702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04459702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa Randomized, Controlled Study of Combination Therapies to Treat COVID-19 Infection
Lead sponsor
ProgenaBiome
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2020
Completion date
December 31, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, coronavirus infection, coronavirus sars-associated as cause of disease classified elsewhere, coronavirus-19, covid, covid-19, sars pneumonia, sars-cov 2